Table 1.
Clinical and pathological features of 37 cases of laryngeal liposarcoma
| Authors | Age | Sex | Location | WHO Histology | Treatment | Rec | Follow-Up | year | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Dockerty [26] | 33 | M | left AEF | Pleo | surgery | Y | DOD | 1968 |
| 2 | Kapur [1] | 61 | M | Larynx, left PS | Myxoid WD | surgery | Y 3 Rec | DOD within 12 m | 1968 |
| 3 | Miller [3] | 43 | M | right FVF | Myxoid WD | TL | N | NED 72 m | 1975 |
| 4 | Velek [4] | 68 | M | right supraglottis | WD | TL | N | NED 80 m | 1976 |
| 5 | Krausen [5] | 67 | M | Epiglottis, right AEF | PD | SL. pRT | N | DOD 72 m | 1977 |
| 6 | Ferlito [6] | 52 | M | left FVF+TVF | Pleo | HL, pRT/TL | Y | NED 72 m | 1978 |
| 7 | Tobey [7] | 61 | M | right vocal cord | PD | SL, Chem | Y | DOD 13 m | 1979 |
| 8 | Gaynor [8] | 59 | M | right AEF, Epiglottis | MX/RDC | SL | N | NED 36 m | 1984 |
| 9 | Shah [9] | 28 | M | Epiglottis | MX/RDC | SL | Y | 32 m | 1984 |
| 10 | Gaynor [8] | 59 | M | Epiglottis, AEF | MX/RDC | SL | Y | 36 m | 1984 |
| 11 | Narula [10] | 45 | M | Larynx | MX/RDC | TL | N | DOD 30 m | 1985 |
| 12 | Allsbrook [11] | 45 | M | left arytenoid | WD | EE/LP×2, EE | Y | 48 m | 1985 |
| 13 | Gadomski [12] | 28 | M | Epiglottis | WD | SE | N | NED 48 m | 1986 |
| 14 | Meis [13] | 54 | M | right AEF | WD | EE/EE, SL, ND, pRT | Y | NED 58 m | 1986 |
| 15 | Gertner [14] | 37 | M | left arytenoid | WD | TL, pRT | N | DOD 24 m | 1988 |
| 16 | Wenig [15] | 49 | M | AEF | WD, 3 cm | SE/SE | Y | NED 72 m | 1990 |
| 17 | Wenig [15] | 65 | F | Epiglottis | WD, 2×2×1.5 cm | SE/SE | Y | NED 480 m | 1990 |
| 18 | Wenig [15] | 57 | M | Epiglottis | WD | SE/SE×2, TL | Y | NED 33 m | 1990 |
| 19 | Wenig [15] | 68 | M | Epiglottis | WD, 3×2×1.5 cm | TL | N | NED 168 m | 1990 |
| 20 | Wenig [15] | 55 | M | right FVF | WD, 6×3 cm, polyp | SE/SE×4, pRT | Y | NED 120 m | 1990 |
| 21 | Esclamado [16] | 34 | M | left AEF | WD | SL | N | NED 15 m | 1994 |
| 22 | McCormick [17] | 62 | M | Larynx | DD | Not doc | Y | Rec 276 m | 1994 |
| 23 | Hurtado [18] | 83 | F | left TVF | WD | EE | N | NED 24 m | 1994 |
| 24 | Wenig [19] | 76 | F | Epiglottis | MX/RDC | LP/TL | Y | DND 12 m | 1995 |
| 25 | Wenig [19] | 44 | M | Epiglottis | MX/RDC | EE/EE, LP | Y | NED 72 m | 1995 |
| 26 | Wenig [19] | 56 | M | right TVF | Pleo | EE/SE | Y | NED 60 m | 1995 |
| 27 | Wenig [19] | 72 | M | Epiglottis | WD | EE/EE×7, LP | Y | NED 120 m | 1995 |
| 28 | Wenig [19] | 56 | M | left AEF | WD | EE/EE×3 | Y | NED 108 m | 1995 |
| 29 | Wenig [19] | 63 | M | right AEF | WD | SL | N | NED 36 m | 1995 |
| 30 | Gal [20] | 63 | M | Larynx | WD | SE | Not doc | Not doc | 1998 |
| 31 | Mandell [21] | 37 | M | left arytenoid | WD | EE/EE | N | RD 122 m | 1999 |
| 32 | Mestre de Juan [22] | 62 | M | right AEF | WD | SL | N | NED 14 m | 1999 |
| 33 | Acharki [23] | 50 | M | FVF | MX/RDC | TL, pRT (50 Gy) | N | NED 18 m | 1999 |
| 34 | Brauchle [24] | 51 | M | Epiglottis | WD | LP | N | NED 18 m | 2001 |
| 35 | Yaqoob [25] | 60 | F | right TVF | MX/RDC | Not doc | Not doc | Not doc | 2006 |
| 36 | Powitzky [2] | 63 | M | left AEF, PS | DD, NOS | LP | N | NED 12 m | 2007 |
| 37 | Present case | 53 | M | right AEF, FVF | WD, 2×1 cm | TL | Y | NED 13 m | 2014 |
Abbreviations: AEF, aryepiglottic fold; Chem, chemotherapy; DD, dedifferentiated; DND, dead of causes other than disease; DOD, dead of disease; EE, endoscopic excision; F, female; FVF, false vocal fold; HL, hemilaryngectomy; LP, laleral pharyngetomy; m, months; M, male; MX, mxyoid; ND, neck disseciion; NED, alive with no evidence of disease; Not doc, not documented in report; PD, poor differentiated; Pleo, pleomorphic; Prt, postoperative radiotherapy; PS, pyriform sinus; RDC, round cell; Rec, recurrence; RT, radiation therapy; SE, simple excision; SL, supragiottic laryngectomy; TL, tolal laryngectomy; TVF, true vocal fold; WD, well differentiated; WHO, World Health Organization.